MYCELX Technologies Corporation
MYX.L · LSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | £0 | £0 | £0 | £0 |
| - Cash | £0 | £0 | £0 | £0 |
| + Debt | £0 | £0 | £0 | £0 |
| Enterprise Value | £0 | £0 | £0 | £0 |
| Revenue | £0 | £0 | £0 | £0 |
| % Growth | -55% | 8.8% | 18.3% | – |
| Gross Profit | £0 | £0 | £0 | £0 |
| % Margin | 27.4% | 35.7% | 44.3% | 38.6% |
| EBITDA | -£0 | -£0 | -£0 | £0 |
| % Margin | -45.4% | -22.6% | -24.8% | 0.2% |
| Net Income | -£0 | -£0 | -£0 | -£0 |
| % Margin | -55.5% | -34% | -39.8% | -16.8% |
| EPS Diluted | -0.12 | -0.16 | -0.18 | -0.073 |
| % Growth | 25% | 11.1% | -145.6% | – |
| Operating Cash Flow | -£0 | -£0 | -£0 | -£0 |
| Capital Expenditures | -£0 | -£0 | -£0 | -£0 |
| Free Cash Flow | -£0 | -£0 | -£0 | -£0 |